Am Heart J

1. WANG W, Gu Y, Wang D, Zhang W, et al
   High-Intensity Interval Training Combined with Moderate-Intensity Continuous Training in Post-PCI Acute Myocardial Infarction Patients: A Randomized Controlled Trial.
   Am Heart J. 2026 May 8:107472. doi: 10.1016/j.ahj.2026.107472.
   

   >> Share

   
   
2. ANDERSON JL, May HT, Winslow T, Le VT, et al
   CorCal Outcomes: a Randomized Trial using the Pooled Cohort Equation or Coronary Artery Calcium to Select Statin Therapy in Primary Prevention Patients. Study Design and Baseline Characteristics.
   Am Heart J. 2026 May 7:107473. doi: 10.1016/j.ahj.2026.107473.
   

   >> Share

   
   

   
   Am J Cardiol

3. PARK EJ, Kang DO, Lee JS, Lee J, et al
   Long-Term Clopidogrel versus Aspirin Monotherapy After Drug-Eluting Stent Implantation: A Nationwide Real-World Comparative Study.
   Am J Cardiol. 2026 May 6:S0002-9149(26)00336.
   

   >> Share

   
   
4. AKBAR UA, Mondal A, Vorla M, Alruwaili W, et al
   Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Obesity Without Diabetes.
   Am J Cardiol. 2026 May 6:S0002-9149(26)00335.
   

   >> Share

   
   

   
   Am J Med

5. NARDIN M, Mehran R, Oliva A, Kedhi E, et al
   From obesity to cardiovascular disease: pathological basis and clinical implications.
   Am J Med. 2026 May 7:S0002-9343(26)00382-7. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   
6. LI X, Wang S, Wang J, Ji Y, et al
   Circulating Apolipoprotein E concentration and incident cardiovascular diseases: evidence from an electronic health record-based cohort.
   Am J Med. 2026 May 6:S0002-9343(26)00376-1. doi: 10.1016/j.amjmed.2026.
   

   >> Share

   
   

   
   Angiology

7. PAN Y, Chen X, Qiu L, Yin C, et al
   Correlation Between Ultrasound-Based Carotid Plaque Characteristics and Coronary Artery Disease Severity: A Retrospective Cross-Sectional Study.
   Angiology. 2026 May 10:33197261447010. doi: 10.1177/00033197261447010.
   

   >> Share

   
   

   
   Ann Thorac Surg

8. HAWKINS RB, Kubi B, Strobel RJ, Paneitz DC, et al
   Long-Term Outcomes of Paroxysmal and Persistent Atrial Fibrillation Management Strategy During Non-Emergent Coronary Artery Bypass Surgery.
   Ann Thorac Surg. 2026 May 13:S0003-4975(26)00444.
   

   >> Share

   
   
9. YU PJ, Newman J, Chang SC, Habib RH, et al
   Optimal Management for Moderate Aortic Stenosis at the Time of Coronary Artery Bypass Grafting.
   Ann Thorac Surg. 2026 May 13:S0003-4975(26)00440.
   

   >> Share

   
   

   
   Arterioscler Thromb Vasc Biol

10. RAMASAMY A, Sivananthan A, Tanboga IH, Kumaran S M T, et al
    Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.
    Arterioscler Thromb Vasc Biol. 2026 May 14. doi: 10.1161/ATVBAHA.126.324466.
    

    >> Share

    
    

    
    BMJ

11. YUAN X, Li J, Lei L, Zhang L, et al
    Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial.
    BMJ. 2026;393:e088939.
    

    >> Share

    
    
12. RAJA SG
    Optimising antiplatelet therapy after coronary artery bypass grafting.
    BMJ. 2026;393:s815.
    

    >> Share

    
    

    
    Can J Cardiol

13. WANG J, Gao W, Wang Z, Zhang F, et al
    Dynamic Changes and Prognostic Value of Angio-derived Index of Microcirculatory Resistance in Acute Myocardial Infarction: A Cohort Study.
    Can J Cardiol. 2026 May 13:S0828-282X(26)00406.
    

    >> Share

    
    

    
    Catheter Cardiovasc Interv

14. ONISHI K, Yasuda M, Yamada N, Soejima N, et al
    Predicting Coronary Occlusion Risk during Redo-TAVR at First TAVR: Asymmetric Calcification Causes Failure.
    Catheter Cardiovasc Interv. 2026;107:1692-1700.
    

    >> Share

    
    
15. SHIBATA N, Morita Y, Kanzaki Y, Watanabe N, et al
    Coronary Perforation and Late Pseudoaneurysm Outcomes After Excimer Laser Angioplasty.
    Catheter Cardiovasc Interv. 2026;107:2050-2059.
    

    >> Share

    
    
16. BESNARD A, Djebbar M, Akodad M, Amour J, et al
    Emergency Mitral Transcatheter Edge-to-Edge Repair as a Bridge to Surgical Mitral Valve Replacement in Cardiogenic Shock: A Case Report.
    Catheter Cardiovasc Interv. 2026 Mar 25. doi: 10.1002/ccd.70578.
    

    >> Share

    
    
17. HOLCK EN, Vadala G, Ayoub M, Gorgulu S, et al
    Procedural Outcome of Modern Percutaneous Coronary Intervention in Proximal Chronic Total Occlusions.
    Catheter Cardiovasc Interv. 2026 Mar 25. doi: 10.1002/ccd.70565.
    

    >> Share

    
    
18. BITAR F, Abou-Karam R, Gady S, Thrompson AG, et al
    Diagnostic Yield and Testing Characteristics of an Invasive Coronary Function Testing Program.
    Catheter Cardiovasc Interv. 2026;107:2022-2031.
    

    >> Share

    
    
19. PONNADA RB, Shah AK, Pujari B, Bhagwat AM, et al
    Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease.
    Catheter Cardiovasc Interv. 2026 Mar 22. doi: 10.1002/ccd.70566.
    

    >> Share

    
    
20. MIKS CD, Ozaki GK, Shukla CR, Sharma V, et al
    Intravascular Lithotripsy Is Associated With Superior Clinical Outcomes Compared to Atherectomy: A Large-Scale, Propensity-Matched Analysis.
    Catheter Cardiovasc Interv. 2026;107:1934-1944.
    

    >> Share

    
    
21. TSIAMIS N, Tsakirian F, Papanikolaou A, Afendoulis D, et al
    Revolutionizing Modern Percutaneous Coronary Intervention: Drug-Coated Balloons for Diabetics With Small Vessel Disease. A Narrative Review.
    Catheter Cardiovasc Interv. 2026 Mar 15. doi: 10.1002/ccd.70550.
    

    >> Share

    
    
22. KIM YL, Noh HW, Seo CO, Park JR, et al
    Plaque Morphology-Dependent Regression of Tandem Coronary Plaques Under Intensive Lipid-Lowering Therapy.
    Catheter Cardiovasc Interv. 2026;107:1917-1921.
    

    >> Share

    
    
23. GHERASIE FA, Ungureanu C
    Successful Management of a Complex Coronary Bifurcation Lesion in Acute Coronary Syndrome Using a Free-Metal Approach.
    Catheter Cardiovasc Interv. 2026;107:1899-1901.
    

    >> Share

    
    
24. LEIBUNDGUT G, Bilal Iqbal M, Ungureanu C, Barmpas A, et al
    Excessive Ostial Stent Protrusion: Evaluation of Management Strategies and Clinical Outcomes of the Side Flap Technique.
    Catheter Cardiovasc Interv. 2026;107:1884-1898.
    

    >> Share

    
    
25. NOORI M, Christiansen EH, Hougaard M, Eftekhari A, et al
    Long-Term Outcomes After Percutaneous Coronary Intervention With the Polymer-Free Biolimus-Coated BioFreedom Stent Versus the Biodegradable-Polymer Sirolimus-Eluting Orsiro Stent in Patients With Acute Coronary Syndromes.
    Catheter Cardiovasc Interv. 2026 Mar 9. doi: 10.1002/ccd.70549.
    

    >> Share

    
    
26. LIO V, Barbero U, Drago S, Persampieri S, et al
    Sheathless Femoral Impella Implantation: A Safer Hemodynamic Support in High-Risk PCI and Cardiogenic Shock.
    Catheter Cardiovasc Interv. 2026;107:1819-1825.
    

    >> Share

    
    
27. MARCHETTA M, Paragliola V, Benedetto D, Sasso S, et al
    Drug-Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes.
    Catheter Cardiovasc Interv. 2026 Mar 3. doi: 10.1002/ccd.70542.
    

    >> Share

    
    
28. KHALAF Y, Atta S, Helal A, Bashir A, et al
    Survival Beyond the Odds: Twelve-Week Follow-Up After Conservative Management of Post-Infarction Ventricular Free Wall Rupture.
    Catheter Cardiovasc Interv. 2026;107:1791-1795.
    

    >> Share

    
    
29. CHANG CC, Lee JY, Chou HL, Sung WT, et al
    Physiologic Assessment Using Angiography-Derived Fractional Flow Reserve After Drug-Coated Balloon Angioplasty in De Novo Coronary Lesions.
    Catheter Cardiovasc Interv. 2026 Feb 24. doi: 10.1002/ccd.70527.
    

    >> Share

    
    
30. MATSUHIRO Y, Egami Y, Nohara H, Kawanami S, et al
    Differences in Vascular Responses and Underlying Mechanisms Following Paclitaxel-Coated Balloon Angioplasty Between Lipid-Rich and Non-Lipid-Rich Lesions in Chronic Coronary Syndrome.
    Catheter Cardiovasc Interv. 2026;107:1732-1742.
    

    >> Share

    
    
31. SHIN ES, Kim S, Kang DO, Choi BJ, et al
    Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.
    Catheter Cardiovasc Interv. 2026;107:1709-1717.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

32. PRICE MJ, Budrys P, Baranauskas A, Toth-Gayor G, et al
    Laser- and Optics-Based Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses: The RESTORE First-In-Human Study.
    Circ Cardiovasc Interv. 2026 May 11:e016874.
    

    >> Share

    
    

    
    Circulation

33. RUEL M, Sandner S, Ponnambalam M, Brown C, et al
    Secondary Prevention After Coronary Artery Bypass Graft Surgery: 2026 Update: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 13. doi: 10.1161/CIR.0000000000001434.
    

    >> Share

    
    

    
    Clin Cardiol

34. FAN X, Zhou T, Li F, Shi G, et al
    Hand Dysfunction After Intervention via Distal Versus Conventional Transradial Access: A Meta-Analysis of Randomized Trials.
    Clin Cardiol. 2026;49:e70350.
    

    >> Share

    
    

    
    Clin Chem

35. RESTAN IZ, Tew YY, Steiro OT, Li Z, et al
    Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction.
    Clin Chem. 2026 May 15:hvag030. doi: 10.1093.
    

    >> Share

    
    
36. 
    Correction to: Cardiac Biomarker Kinetics in Patients after Coronary Artery Bypass Grafting with an Uncomplicated Course.
    Clin Chem. 2026 May 12:hvag054. doi: 10.1093.
    

    >> Share

    
    

    
    Eur Heart J

37. HOLMGREN L, von Koch S, Andell P, Sorensson P, et al
    Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease.
    Eur Heart J. 2026 May 11:ehag216. doi: 10.1093.
    

    >> Share

    
    
38. LORUSSO R, Matteucci M, Ronco D, Massimi G, et al
    Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction.
    Eur Heart J. 2026 May 11:ehag164. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

39. TSAI TY, Aldujeli A, Haq A, Murphy P, et al
    Diagnostic performance of exercise stress testing findings and coronary microvascular dysfunction in patients with angina with non-obstructive coronary artery disease.
    Heart. 2026;112:615-623.
    

    >> Share

    
    
40. KIVIMAKI K, Rankinen J, Lyytikainen LP, Pohjantahti H, et al
    Frontal T-wave axis deviation and risk of sudden cardiac death in coronary syndromes.
    Heart. 2026;112:598-605.
    

    >> Share

    
    

    
    Int J Cardiol

41. KROLL C, Hubert A, Saccardi L, Martinez Pereyra V, et al
    (Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.
    Int J Cardiol. 2026;456:134518.
    

    >> Share

    
    
42. GIOVACHINI L, Ferrante A, Guedeney P, Rahoual G, et al
    Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study.
    Int J Cardiol. 2026;456:134506.
    

    >> Share

    
    
43. GADELMAWLA AF, Taha AM, Alkuwaiti FA, Alkuwaiti MA, et al
    Prognostic impact of persistent microvascular obstruction on cardiac magnetic resonance after STEMI: A systematic review and meta-analysis.
    Int J Cardiol. 2026;456:134523.
    

    >> Share

    
    

    
    J Am Coll Cardiol

44. MEHRAN R
    A Window Closed, A World Opened: Leadership, Legacy, and the Future of Cardiovascular Care.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)06348.
    

    >> Share

    
    
45. CLARK MG, Levin MG
    Polygenic Risk Scores for Cardiovascular Disease: Closing the Gap Between Prediction and Practice.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)06012.
    

    >> Share

    
    
46. SCHAFFER JM, Shih E, Squiers JJ, Banwait JK, et al
    Multiarterial Grafting and Survival After Coronary Artery Bypass Grafting: An Instrumental Variable Analysis.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)05875.
    

    >> Share

    
    

    
    J Electrocardiol

47. GORGELS APM
    The electrophysiologic continuum of occlusion myocardial infarction.
    J Electrocardiol. 2026;96:154271.
    

    >> Share

    
    
48. SETOGUCHI T, Matsumoto N, Matsunaga Y, Otsuka N, et al
    Comparison of measured and synthesized right-sided precordial electrocardiograms in patients with right ventricular infarction.
    J Electrocardiol. 2026;97:154273.
    

    >> Share

    
    

    
    JAMA

49. LIU X, Zhang F, Zhang C, Li Z, et al
    Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial.
    JAMA. 2026 May 8:e265245. doi: 10.1001/jama.2026.5245.
    

    >> Share

    
    
50. 
    Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: Research Summary.
    JAMA. 2026 May 8:e265288. doi: 10.1001/jama.2026.5288.
    

    >> Share

    
    
51. ANDERER S
    Syphilis Linked to Higher Risk of Some Cardiovascular Outcomes.
    JAMA. 2026 May 8. doi: 10.1001/jama.2026.2132.
    

    >> Share

    
    

    
    Mol Cell Biochem

52. FENG N, Zhang A, Yao L, Tang J, et al
    Puerarin alleviates myocardial ischemia-reperfusion injury by enhancing FUNDC1-mediated mitophagy.
    Mol Cell Biochem. 2026 May 12. doi: 10.1007/s11010-026-05567.
    

    >> Share

    
    
53. HUANG Z, Chen X, Ren J, Wan L, et al
    Dose- and time-dependent cardioprotection of liproxstatin-1 via sequential modulation of ferroptosis pathways after myocardial ischemia-reperfusion.
    Mol Cell Biochem. 2026 May 13. doi: 10.1007/s11010-026-05543.
    

    >> Share

    
    

    
    N Engl J Med

54. CACOULIDIS C
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:1964.
    

    >> Share

    
    
55. FAUCHIER L, Guglieri M
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:1964-1965.
    

    >> Share

    
    
56. LEE SJ, Yu HT, Kim JS
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents. Reply.
    N Engl J Med. 2026;394:1965-1966.
    

    >> Share

    
    
57. HINGORANI AD, Wald NJ
    The Inherited Basis of Coronary Artery Disease.
    N Engl J Med. 2026;394:1966-1967.
    

    >> Share

    
    
58. SCHUNKERT H, Natarajan P, Samani NJ
    The Inherited Basis of Coronary Artery Disease. Reply.
    N Engl J Med. 2026;394:1967-1968.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share